Vanguard Fiduciary Trust’s BioCardia BCDA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.2K	Hold	66,270	–	–	﹤0.01%	3775
2026 Q1	$80.2K	Buy	+66,270	New	+$82.9K	﹤0.01%	3748

Other funds holding BCDA

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust's BCDA Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its BioCardia (BCDA) position steady in Q2 2026 at 66,270 shares worth $82.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3775.

Vanguard Fiduciary Trust first reported a position in BCDA in Q1 2026 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Vanguard Fiduciary Trust held 66,270 shares of BioCardia worth $82.2K as of Q2 2026.
Vanguard Fiduciary Trust left its BioCardia share count unchanged in Q2 2026.
BioCardia made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3775 holding.
Vanguard Fiduciary Trust first reported a position in BioCardia in Q1 2026 and has held it in 2 quarters since.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.